Generic Name: Rivaroxaban
Brand Name: Xarelto
Manufacturer: Bayer Inc.
Therapeutic Area: Deep-vein thrombosis without symptomatic pulmonary embolism
Indications: Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: August 16, 2012
Recommendation Type: List with clinical criteria and/or conditions